Publications and Presentations
01/05/21 – Blog
Brenda M. Maloney Shafer The End of a Wild Year for 340B: HHS Issues Advisory Opinion and New GAO Report Sheds Light on HRSA’s Enforcement Pullback To Be Or Not To 340B Brenda M. Maloney Shafer, Richard B. Davis, David M. Blank2020 was a tumultuous year for virtually everyone and everything, and the 340B Program was no exception. As we outlined in previous articles, many drug manufacturers have decided that the Health Resources and Services Administration’s Office of Pharmacy Affairs (“HRSA... Read More
10/06/20 – Newsletter
DOJ Focuses on Health Care Fraud Schemes Involving Telemedicine & Health Care Facilities White Collar Crime and Internal Investigations Alert Luke Cass, Hector J. Diaz, David M. Blank
05/08/20 – Newsletter
Connolly Revisited: Striking the Right Balance Between Conducting an Effective Internal Investigation and Serving as the Government’s Alter Ego White Collar Crime and Internal Investigations Alert Luke Cass, David M. Blank
03/16/20 – Newsletter
The Travel Act in Federal Health Care Fraud Prosecutions White Collar Crime and Internal Investigations Alert Luke Cass, David M. Blank, Hector J. Diaz, Mark W. Bina
12/18/19 – Article
"OIG Proposed Revisions to AKS Safe Harbor Rules: Implications for Life Sciences Stakeholders" American Health Lawyers Association (AHLA) David M. Blank
07/17/19
"Enforcement Rx: An Overview of Recent Government Actions Target Fraud, Waste, And Abuse in the Pharmacy Sector" Quarles & Brady Pharmacy Law Symposium
04/23/19 – Newsletter
ARPO Strike Force Announces Expansion and First Major Takedown OIG Monitor Alert David M. Blank, Luke Cass
09/07/18 – Article
“A Look At OIG's Medicare Exclusion Analysis Under FCA” Law360 David Blank
08/28/18 – Newsletter
Can You Hear Me Now? OIG Examines Improper Telehealth Payments OIG Monitor David Blank
08/28/18 – Newsletter
OIG by the Numbers - June, 2018 OIG Monitor David Blank
08/28/18 – Newsletter
The GAO Provides Congress Inside Look at OIG Integrity Obligations OIG Monitor David Blank
08/28/18 – Newsletter
OIG Testimony Focuses on Longstanding 340B Program Vulnerabilities OIG Monitor David Blank
07/18/18 – Newsletter
OIG Exercises Discretion, Authorizes Free Caregiver Support Services OIG Monitor David Blank
07/12/18 – Newsletter
Pharmacy Chain Takes Center Stage in Latest DOJ-OIG Takedown OIG Monitor David Blank, Cory J. Kopitzke
07/05/18 – Newsletter
Minding the Gap: OIG Green Light of Medigap Arrangements with PHOs Continues OIG Monitor David Blank
06/26/18 – Newsletter
OIG Greenlights Free Telemedicine Equipment Aimed at HIV Prevention OIG Monitor David Blank
06/01/18 – Newsletter
When Waste is NOT “Waste”: OIG Deems Free Ostomy Samples As Low Risk OIG Monitor David Blank
05/15/18 – Newsletter
OIG by the Numbers January - March, 2018 OIG Monitor David Blank
05/15/18 – Newsletter
Second Acts: Exclusion, Reinstatement, and Revocation Oh My! OIG Monitor David Blank, Christopher Guthrie
05/15/18 – Newsletter
Problematic Physical Therapy Billing Remains an OIG Priority OIG Monitor David Blank, Cory Kopitzke
05/15/18 – Newsletter
OIG Blesses Arrangement Involving "Far Removed" Excluded Person OIG Monitor David Blank, Elizabeth Gebarski
05/15/18 – Newsletter
OIG Data Analytics Nab More Fraudulent Pelvic Floor Therapy Providers OIG Monitor David Blank
05/15/18 – Presentation
"False Claims Act Trends Impacting Organizational Compliance" Quarles & Brady Seminar David Blank
05/15/18 – Newsletter
OIG Closes the Book on Rescinding Advisory Opinion 06-04 OIG Monitor David Blank, Sam Magnuson
04/01/18 – Article
"The Government Crackdown on Absentee Providers" Chicago Medicine David Blank
03/26/18 – Presentation
"Fraud and Abuse in the Managed Care Setting" AmeriHealth Caritas David M. Blank
02/07/18 – Newsletter
Guidance Dethroned: What the Brand Memorandum Means to Health Care Entities Health Law Alert David M. Blank
01/16/18 – Newsletter
The Government Crackdown on the Absentee Provider Continues Health Law Alert David M. Blank